Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TG4010 and Nivolumab in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Trial of BMS-986012 in Combination With Platinum and Etoposide
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab for Head and Neck Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
- Status
- UNKNOWN
- Phase
- PHASE1
Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC
- Status
- COMPLETED
- Phase
- N/A
Interferon Toxicities in Melanoma Treatment
- Status
- COMPLETED
- Phase
- N/A
Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
- Status
- COMPLETED
- Phase
- N/A
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy
- Status
- COMPLETED
- Phase
- N/A
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
- Status
- COMPLETED
- Phase
- N/A
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
- Status
- COMPLETED
- Phase
- PHASE3
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE1
Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
- Status
- COMPLETED
- Phase
- N/A
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE3
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1